Cytokine and Adipokine Levels in Patients with Premalignant Oral Lesions or in Patients with Oral Cancer Who Did or Did Not Receive 1α,25-Dihydroxyvitamin D3 Treatment upon Cancer Diagnosis
| Autor: | Corinne A. Levingston, Sara D. Johnson, M. Young |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2015 |
| Předmět: |
Cancer Research
medicine.medical_specialty medicine.medical_treatment Adipokine Inflammation Gastroenterology lcsh:RC254-282 HNSCC Article Proinflammatory cytokine 03 medical and health sciences 0302 clinical medicine Immune system Internal medicine medicine adipokines Adiponectin business.industry Leptin Cancer cytokines inflammation oral cancer premalignant lesions medicine.disease lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens 3. Good health stomatognathic diseases Cytokine Oncology 030220 oncology & carcinogenesis Immunology medicine.symptom business 030215 immunology |
| Zdroj: | Cancers Cancers, Vol 7, Iss 3, Pp 1109-1124 (2015) Cancers; Volume 7; Issue 3; Pages: 1109-1124 Volume 7 Issue 3 Pages 1109-1124 |
| ISSN: | 2072-6694 |
| Popis: | Differences in levels of inflammation-modulating cytokines and adipokines in patients with premalignant oral lesions versus in patients that develop squamous cell carcinoma of the head and neck (HNSCC) were assessed. Also assessed was the impact of treating HNSCC patients with the immune regulatory mediator, 1α,25-dihydroxyvitamin D3 [1,25(OH)2D3], on modulators of inflammation. Compared to healthy controls, patients with premalignant oral lesions had increases in their systemic levels of the inflammatory cytokines IL-6 and IL-17, and increases in the adipokine, leptin. However, levels of these pro-inflammatory cytokines and adipokine were reduced in patients with HNSCC. Treatment of HNSCC patients with 1,25(OH)2D3 increased levels of each of the measured immune mediators. Levels of the anti-inflammatory adipokine, adiponectin, were shifted inversely with the levels of the pro-inflammatory cytokines and with leptin. These studies demonstrate heightened immune reactivity in patients with premalignant lesions, which wanes in patients with HNSCC, but which is restored by treatment with 1,25(OH)2D3. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|